Background: Silicone breast implants have been used for post-mastectomy breast reconstruction and cosmetic augmentation since the 1960s. Recent regulatory action has resulted in a few devices being suspended or cancelled from the Australian market.
Objective: The aim of this article is to summarise important clinical information on how best to assess women with breast implants, and recognise and manage adverse events related to these devices.
Discussion: It is hoped that this article will be a valuable aid to primary care practice in view of the increasing number of patients who will need ongoing surveillance and care.